Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longtengtongluo wine is a Traditional Chinese Medicine (TCM) medicinal liquor developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically formulated as a hospital preparation for the management of cancer-related pain, particularly pain resulting from bone metastases. The preparation is based on the TCM principles of 'activating blood, resolving stasis, and unblocking collaterals' to provide analgesic effects. It is typically applied topically to the affected areas. The formula contains various herbal ingredients, such as vine-based plants (e.g., Sargentodoxa cuneata), which are traditionally used to treat joint and bone pain by improving local circulation and reducing inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Longtengtongluo wine.